• DOI:10.1186/s12879-015-1136-0
• Corpus ID: 17894014

First human case report of sepsis due to infection with Streptococcus suis serotype 31 in Thailand

@article{Hatrongjit2015FirstHC,
  title={First human case report of sepsis due to infection with Streptococcus suis serotype 31 in Thailand},
  author={Rujirat Hatrongjit and Anusak Kerdsin and Marcelo Gottschalk and Dan Takeuchi and Shigeyuki Hamada and Kazunori Oishi and Yukihiro Akeda},
  journal={BMC Infectious Diseases},
  year={2015},
  volume={15}
}

• Rujirat Hatrongjit, A. Kerdsin, +4 authors Y. Akeda
• Published 30 September 2015
• Medicine, Biology
• BMC Infectious Diseases

BackgroundStreptococcus suis is a zoonotic pathogen that causes invasive infections in humans and pigs. It has been reported that S. suis infection in humans is mostly caused by serotype 2. However, human cases caused by other serotypes have rarely been reported. This is the first report of a human case of infection with S. suis serotype 31 in Thailand.Case presentationA 55-year-old male alcohol misuser with liver cirrhosis was admitted with sepsis to a hospital in the Central Region of Thailand. He had consumed a homemade, raw pork product prior to the onset of illness. He was alive after treatment with ceftriaxone and no complication occurred. An isolate from blood culture at the hospital was suspected as viridans group Streptococcus. It was confirmed at a reference laboratory as S. suis serotype 31 by biochemical tests, 16S rDNA sequencing, and multiplex polymerase chain reaction for serotyping, but it was untypable by the co-agglutination test with antisera against recognized S. suis serotypes, suggesting loss of capsular material. The absence of a capsule was confirmed by transmission electron microscopy. The isolate was confirmed to be sequence type 221, with 13 putative virulence genes that are usually found in serotype 2 strains.ConclusionWe should be aware of the emergence of S. suis infections caused by uncommon serotypes in patients with predisposing conditions. Laboratory capacity to identify S. suis in the hospital is needed in developing countries, which can contribute to enhanced surveillance, epidemiological control, and prevention strategies in the prevalent area.